In the published article, there was an error. There is a clerical error in our article. On the page 5, the word “increase” should actually be “decrease”. So, it should read, “The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
A correction has been made to Candidate RNA Molecules as Biomarkers for CRC.
lncRNAs as Biomarkers for CRC, Paragraph 3. This sentence previously stated:
“The upregulation of CCAT1 expression increases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
The corrected sentence appears below:
“The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.